HOME Research Insight The Proteases Market is Highly Fragmented and Competitive with Leading Players



The Proteases Market is Highly Fragmented and Competitive with Leading Players


The proteases market is highly fragmented and competitive with leading players such as Chr. Hansen Holdings A/S (Denmark), E.I. du Pont de Nemours and Company (U.S.), Associated British Foods plc (U.K.), Koninklijke DSM N.V. (The Netherlands), and Novozymes A/S (Denmark). Other players include Dyadic International Incorporated (U.S.), Advanced Enzyme Technologies Ltd. (India), Biocatalysts Limited (U.K.), Amano Enzyme Inc. (Japan), and Specialty Enzymes and Biotechnologies (U.S.). The proteases market is projected to reach USD 2.21 billion at a CAGR of 6% from 2016 to 2021. The key driving factors of the proteases market include growing industrialization, adoption of advanced technology, and increasing application spectrum of proteases along with increasing disposable income.

Key strategies such as expansions and investments, partnerships, agreements & collaboration, new product launches, and acquisitions have been adopted by the key players to meet the increasing demand of proteases. Leading players actively invest in R&D activities to offer diversified product portfolios, focus on competitive reach in the proteases market, and make use of the opportunity to increase its geographical footprint and also improve its distribution network through the means of vertical integration.

Novozymes A/S (Denmark)

Novozymes A/S (Denmark) manufactures a wide range of enzymes and microorganisms used in food production, animal feed, and textile enzymes (used in desizing and biopolishing). It carries out its operations under five business segments, namely, bioenergy, agriculture & feed, proteases & pharma, food & beverages, and household care, and delivers business-to-business biological solutions used in the production of various kinds of products such as biofuel, detergents, and feed & crops. It offers its products globally through its subsidiaries in 130 countries and has more than 700 products. The company operates worldwide including Europe, the Americas, the Middle East, Africa, and Asia-Pacific. The company has launched innovative enzyme products for textile and industrial processes, animal nutrition, and pet feed, and invests in providing innovative products with proteases enzymes so as to boost its current product portfolio. As global consumption and demand for sustainable business practices continue to grow, industrial biotechnology is positioned to be part of the solution to many of the world’s challenges. Thus, as the market for bio-technology is expanding, Novozymes, being the market leader, has an added advantage compared to other market players to capture and maintain its position by effectively utilizing its resources. It also focuses on increased penetration in existing markets, expansion in global markets, and rapid development in R&D for long-term growth in the enzymes business and make its product portfolio more comprehensive for the proteases enzyme market. For instance, in June 2015, it opened an innovation center in Lyngby which conducts research and aims at understanding customers’ needs. The innovation center would help the company to strengthen the company’s biotechnology and help in innovating products using biotechnology.

Koninklijke DSM N.V. (The Netherlands)

Koninklijke DSM N.V. is engaged in health, nutrition, and materials business. It operates through five segments, namely, nutrition, performance materials, polymer intermediates, innovation center, and corporate activities. It manufactures food enzymes for food & beverage industries, feed enzymes for animal nutrition, and products like vitamins and carotenoids for pharmaceutical and personal care industries. The company provides enzyme products in approximately 17 global markets for animal nutrition, human nutrition, and textiles & clothing and has its operations in Asia, Australia, Africa, Americas, North America, and Europe. It aims to expand its market by strategic decisions of acquisitions which would increase the enzyme business. Its investments in R&D activities help in understanding the requirements of customers and innovate new products for the market. It encourages the involvement of the stakeholders which can help in creating value for the company. For instance, in March 2015, Koninklijke DSM N.V. (The Netherlands) opened a Nutrition Innovation Center in Singapore which will help the company in understanding the needs of the consumers in Singapore and nearby countries and also strengthen the nutrition science and technology ecosystem in Singapore. Also, in December 2012, it acquired the cultures and enzymes business of Cargill Inc. (U.S.) which will help the company to become a global Tier 1 dairy enzymes supplier.

Related Reports:

Proteases Market by Source (Microbial, Animal, Plant), Formulation (Liquid, Lyophilized Powder), Product (Renin, Papain, Alkaline), Application (Food & Beverages, Feed, Soaps & Detergents, Pharmaceutical), & by Region - Global Forecast to 2021

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports